RNA interference

This page shows the latest RNA interference news and features for those working in and with pharma, biotech and healthcare.

ACPs to lead gene therapies in haemophilia market growth

The two drugs have distinct mechanisms – Hemlibra is a bispecific factor IXa- and factor X-directed antibody, while fitusiran is an RNA interference (RNAi) therapeutic targeting the endogenous anticoagulant antithrombin (AT) –

Latest news

Twentyeight-Seven raises another $15m for non-coding RNA drugs

This is a different approach to the emerging class of RNA therapeutics that target RNA that is directly involved in protein expression, such as antisense and RNA interference (RNAi) drugs from ... leader in capitalising on the emerging science around RNA
Biotech now vital to pipelines – but success rates falling

first RNA interference (RNAi) therapy and Lox/Bayer’s NTRK gene fusion – targetting Vitrakvi (larotrectinib).
Alnylam swaps Sanofi for Regeneron as R&D partner

The new deal – announced just after Sanofi and Alnylam dissolved a rare disease R&D partnership set up in 2014 – will see Regeneron pay $400m upfront to the RNA interference specialist
Sanofi exits R&D pact with Alnylam on rare disease

Sanofi and Alnylam started working together on gene-silencing therapies in 2014, with the French drugmaker’s rare disease unit Genzyme making a $700m investment in the RNA interference specialist and
Moderna CEO makes case for firm’s lofty valuation

Moderna’s specialty is in messenger RNA (mRNA) drugs which are designed to turn a patient’s own cells into drug-manufacturing factories, hijacking the cellular machinery involved in protein production. ... It’s potentially a whole new drug class,

More from news
Approximately 1 fully matching, plus 36 partially matching documents found.

Latest appointments

Silence appoints chief medical officer

These studies involve Silence's investigational portfolio of RNA interference (RNAi) therapeutics, which aim to treat conditions by selectively turning off genes expressed in an individual with a certain disease.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

FREELANCE Account Director – Healthcare Advertising – London – 3...: Competitive Daily Rates

Account Director - Medical Communications - London / South East: Excellent Salary and Benefits on offer

Account Director – UK Office: Excellent salary and benefits

Account Director - Healthcare Advertising - London - 2 DAYS HOME...: £50000 - £70000

Account Director, Healthcare Communications: Salary TBC

FREELANCE Medical Writer (Initial 2/ 3 months term) - London Off...: Excellent Daily Rate

Account Director – London based Medical Communications Agency: Excellent Remuneration Package

Senior Account Executive – Account Manager – Healthcare Advertis...: £32000 - £43000 Bonus Benfits

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Strategic Planner, Healthcare Advertising Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

The relevance of patient perspectives to value: Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?: Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
The evolution of real-world studies: How industry and regulators are using real-world data...